• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Globus Medical Inc.

    4/25/25 4:24:50 PM ET
    $GMED
    Medical/Dental Instruments
    Health Care
    Get the next $GMED alert in real time by email
    DEFA14A 1 gmed-20250604xdefa14a.htm DEFA14A 2025 Note Card

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    

    

    SCHEDULE 14A

    

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No.    )

    

    

    

     

     

     

     

    Filed by the Registrant   ☒

    Filed by a Party other than the Registrant   ☐

    

     

     

     

     

    Check the appropriate box:

    

     

     

     

     

    ☐

     

    Preliminary Proxy Statement

    ☐

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

     

    Definitive Proxy Statement

    ☒

     

    Definitive Additional Materials

    ☐

     

    Soliciting Material Pursuant to §240.14a-12

    

    

    GLOBUS MEDICAL, INC.

    (Name of Registrant as Specified in Its Charter)

    

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    

    Payment of Filing Fee (Check the appropriate box):

    

     

    ☒

     

    No fee required.

    ☐

     

    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

    

     

     

    

     

    (1)

     

    Title of each class of securities to which transaction applies:

    

     

     

     

     

    

     

    (2)

     

    Aggregate number of securities to which transaction applies:

    

     

     

     

     

    

     

    (3)

     

    Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

    

     

     

     

     

    

     

    (4)

     

    Proposed maximum aggregate value of transaction:

    

     

     

     

     

    

     

    (5)

     

    Total fee paid:

    

    

    

     

    ☐

     

    Fee paid previously with preliminary materials.

    

     

    ☐

     

    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

    

     

     

    

     

    (1)

     

    Amount Previously Paid:

    

     

     

     

     


     

    

     

    (2)

     

    Form, Schedule or Registration Statement No.:

    

     

     

     

     

    

     

    (3)

     

    Filing Party:

    

     

     

     

     

    

     

    (4)

     

    Date Filed:

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    


     

    Picture 2


     

    Picture 3

    

    


    Get the next $GMED alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GMED

    DatePrice TargetRatingAnalyst
    5/27/2025Buy → Neutral
    BTIG Research
    1/10/2025$97.00Underperform → Neutral
    BofA Securities
    12/2/2024$83.00 → $100.00Equal-Weight → Overweight
    Morgan Stanley
    8/7/2024$60.00 → $78.00Equal Weight → Overweight
    Wells Fargo
    5/20/2024$60.00 → $80.00Neutral → Overweight
    Piper Sandler
    3/18/2024$60.00Neutral → Buy
    BTIG Research
    10/20/2023$75.00Buy
    ROTH MKM
    9/19/2023$61.00Hold → Buy
    Stifel
    More analyst ratings